Scholars Central

Conference abstractPublished 7 Dec 2015

Nuclear transport inhibitors alter capsid sub-cellular localization and replication of Venezuelan Equine Encephalitis virus and related new world Alphaviruses

Authors: Kylie M Wagstaff, Lindsay Lundberg, Chelsea Pinkham, Ashwini Benedict, Nazly Shafagati, Moushimi Amaya, Aarthi Narayanan, David Thomas, Aaron De Bono, Jonathan Baell, David A Jans, Sharon Tamir, Kylene Kehn-Hall

Monash University, Australia; George Mason University, USA; Karyopharm Therapeutics, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

New world alpha-viruses such as Eastern, Venezuelan and Western Equine Encephalitis Viruses (EEEV, VEEV and WEEV) cause high mortality and morbidity in equines and humans and are characterized by a febrile illness that may progress into encephalitis. The centers for disease control and prevention consider all three viruses Category B agents due to their ease of weaponization and the lack of licensed vaccines or therapeutics. The VEEV structural capsid protein blocks nuclear import in mammalian cells, most likely by forming a trimeric complex with the host nuclear import (importin Ã?±/Ã?²1) and export (CRM1) machinery. This complex sits inside the nuclear pore comples, the only transit for protein movement between cytoplasm and nucleus and prevents host protein movement, thus inhibiting the host anti-viral response, possibly due to its complexing with the host CRM1 and importin Ã?±/Ã?²1 nuclear transport proteins. Inhibition of viral protein nuclear transport is a rapidly growing area of investigation and hence nuclear transport inhibitors were investigated for their effects on capsid. Utilizing numerous transport inhibitors and a combination of in vitro protein binding assays with advanced quantitative confocal microscopy of transfected and infected cells as well as viral replication assays we demonstrate that VEEV capsid nuclear transport is a viable target for therapeutic intervention, resulting in reduced viral replication. Similarly other New World alpha viruses are also susceptible to these compounds suggesting for the first time that a pan-antiviral therapeutic may be possible.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Antivirals & Antiretrovirals.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Antivirals & Antiretrovirals
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Kylie M Wagstaff”
  • BylineArticles whose byline prints “Lindsay Lundberg”
  • BylineArticles whose byline prints “Chelsea Pinkham”
  • BylineArticles whose byline prints “Ashwini Benedict”
  • BylineArticles whose byline prints “Nazly Shafagati”
  • BylineArticles whose byline prints “Moushimi Amaya”
  • BylineArticles whose byline prints “Aarthi Narayanan”
  • BylineArticles whose byline prints “David Thomas”